Medicare billing address
CMS Medicare provider billing file
240 Middletown Blvd Ste 205Langhorne, PA 19047
CMS public data · NPI 1124552435
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Ian Garrahy, D.O.
Specialty
Credential
D.O.
NPI
1124552435
Primary source state
PA
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Ian Garrahy, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
240 Middletown Blvd Ste 205CMS Doctors & Clinicians file
240 Middletown BlvdCMS Doctors & Clinicians file
3400 Civic Ctr BlvdCMS Doctors & Clinicians file
777 Township Line RdIn the 2024 CMS provider billing file, this NPI had 895 Medicare beneficiaries and 236,285 total services. The average beneficiary age was 74, and the average HCC risk score was 1.8.
Total Medicare allowed amount
$3,842,472.52
Total Medicare payment amount
$3,046,106.40
Medicare beneficiaries
895
Total services
236,285
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
42%
CMS beneficiary-panel share
Diabetes
38%
CMS beneficiary-panel share
Chronic kidney disease
37%
CMS beneficiary-panel share
Anxiety
31%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, ferric carboxymaltose, 1 mg | 121,578 | $1.10 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,040 | $49.21 |
| Injection, pembrolizumab, 1 mg | 8,160 | $56.37 |
| Injection, denosumab, 1 mg | 6,960 | $25.27 |
| Injection, fosaprepitant, 1 mg | 6,450 | $0.14 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,350 | $8.00 |
| Injection, rituximab, 10 mg | 1,853 | $76.83 |
| Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,440 | $46.50 |
| Injection, palonosetron hcl, 25 mcg | 1,310 | $0.89 |
| Injection, leucovorin calcium, per 50 mg | 913 | $4.50 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1124552435. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Eliquis | Apixaban | 84 | 148 | $82,705.31 |
| 2 | Pomalyst | Pomalidomide | 19 | 19 | $397,825.31 |
| 3 | Acyclovir | Acyclovir | 17 | 17.8 | $257.54 |
| 4 | Anastrozole | Anastrozole | 17 | 51.7 | $731.81 |
| 5 | Xarelto | Rivaroxaban | 16 | 48 | $25,783.83 |
| 6 | Prednisone | Prednisone | 14 | 14 | $88.32 |
| 7 | Oxycodone Hcl | Oxycodone Hcl | 13 | 13 | $66.76 |
| 8 | Revlimid | Lenalidomide | 12 | 12 | $213,110.08 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of New England, College Of Osteo Medicine
Graduation year
2017
Group/practice field
Clinical Care Associates Of The University Of Pennsylvania Health.
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.